Marianela Vara-Messler

Marianela Vara-Messler

Auto-generated profile, based on publicly available information

Marianela Vara-Messler

Instituto de Investigaciones en Ciencias de la Salud de Córdoba (INICSA-CONICET), Universidad Nacional de Córdoba, Enrique Barros s/n. Ciudad Universitaria, 5000, Córdoba, Argentina

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2019 in Cells
Verified
Journal Article
Open access
PDF file
GCGIULIA CHIAVERINA
GIULIA CHIAVERINA
LBLaura Di Blasio
Laura Di Blasio
VMValentina Monica
Valentina Monica
MAMassimo Accardo
Massimo Accardo
MPMiriam Palmiero
Miriam Palmiero
LPLuca Primo
Luca Primo
Vascular physiology relies on the concerted dynamics of several cell types, including pericytes, endothelial, and vascular smooth muscle cells. The interactions between such cell types are inherently dynamic and are not easily described with static, fixed, experimental approaches. Pericytes are mural cells that support vascular development, remodeling, and homeostasis, and are involved in a number of pathological situations including cancer. The dynamic interplay between pericytes and endothelial cells is at the basis of vascular physiology and few experimental tools exist to properly describe and study it. Here we employ a previously developed ex vivo murine aortic explant to study the formation of new blood capillary-like structures close to physiological situation. We develop several mouse models to culture, identify, characterize, and follow simultaneously single endothelial cells and pericytes during angiogenesis. We employ microscopy and image analysis to dissect the interactions between cell types and the process of cellular recruitment on the newly forming vessel. We find that pericytes are recruited on the developing sprout by proliferation, migrate independently from endothelial cells, and can proliferate on the growing capillary. Our results help elucidating several relevant mechanisms of interactions between endothelial cells and pericytes.

18 November 2015 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
MVMarianela Vara-Messler
Marianela Vara-Messler
MPMaria E. Pasqualini
Maria E. Pasqualini
ACAndrea Comba
Andrea Comba
RSRenata Silva
Renata Silva
CBCarola Buccellati
Carola Buccellati
MVMirta A. Valentich
Mirta A. Valentich

17 January 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DSDesiana Somale
Desiana Somale
GNGiovanna Di Nardo
Giovanna Di Nardo
LBLaura Di Blasio
Laura Di Blasio
APAlberto Puliafito
Alberto Puliafito
MVMarianela Vara-Messler
Marianela Vara-Messler
PGPaolo Armando Gagliardi
Paolo Armando Gagliardi
The activation of the majority of AGC kinases is regulated by two phosphorylation events on two conserved serine/threonine residues located on the activation loop and on the hydrophobic motif, respectively. In AGC kinase family, phosphomimetic substitutions with aspartate or glutamate, leading to constitutive activation, have frequently occurred at the hydrophobic motif site. On the contrary, phosphomimetic substitutions in the activation loop are absent across the evolution of AGC kinases. This observation is explained by the failure of aspartate and glutamate to mimic phosphorylatable serine/threonine in this regulatory site. By detailed 3D structural simulations of RSK2 and further biochemical evaluation in cells, we show that the phosphomimetic residue on the activation loop fails to form a critical salt bridge with R114, necessary to reorient the αC-helix and to activate the protein. By a phylogenetic analysis, we point at a possible coevolution of a phosphorylatable activation loop and the presence of a conserved positively charged amino acid on the αC-helix. In sum, our analysis leads to the unfeasibility of phosphomimetic substitution in the activation loop of RSK and, at the same time, highlights the peculiar structural role of activation loop phosphorylation.

23 November 2019 in Nutrition
Verified
Journal Article
Closed access
MVMarianela Vara-Messler
Marianela Vara-Messler
JMJorge Humberto Mukdsi
Jorge Humberto Mukdsi
NONatalia I. Osieki
Natalia I. Osieki
EBEvangelina Benizio
Evangelina Benizio
GRGastón M. Repossi
Gastón M. Repossi
NGNestor Garcia
Nestor Garcia

1 January 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ACAndrea Comba
Andrea Comba
LALuciana L. Almada
Luciana L. Almada
ETEzequiel Tolosa
Ezequiel Tolosa
EIEriko Iguchi
Eriko Iguchi
DMDavid L. Marks
David L. Marks
Martin Fernandez-ZapicoMartin Fernandez-Zapico
Martin Fernandez-Zapico
Numerous reports have demonstrated a tumor inhibitory effect of polyunsaturated fatty acids (PUFAs). However, the molecular mechanisms modulating this phenomenon are in part poorly understood. Here, we provide evidence of a novel antitumoral mechanism of the PUFA arachidonic acid (AA). In vivo and in vitro experiments showed that AA treatment decreased tumor growth and metastasis and increased apoptosis. Molecular analysis of this effect showed significantly reduced expression of a subset of antiapoptotic proteins, including BCL2, BFL1/A1, and 4-1BB, in AA-treated cells. We demonstrated that down-regulation of the transcription factor glioma-associated protein 1 (GLI1) in AA-treated cells is the underlying mechanism controlling BCL2, BFL1/A1, and 4-1BB expression. Using luciferase reporters, chromatin immunoprecipitation, and expression studies, we found that GLI1 binds to the promoter of these antiapoptotic molecules and regulates their expression and promoter activity. We provide evidence that AA-induced apoptosis and down-regulation of antiapoptotic genes can be inhibited by overexpressing GLI1 in AA-sensitive cells. Conversely, inhibition of GLI1 mimics AA treatments, leading to decreased tumor growth, cell viability, and expression of antiapoptotic molecules. Further characterization showed that AA represses GLI1 expression by stimulating nuclear translocation of NFATc1, which then binds the GLI1 promoter and represses its transcription. AA was shown to increase reactive oxygen species. Treatment with antioxidants impaired the AA-induced apoptosis and down-regulation of GLI1 and NFATc1 activation, indicating that NFATc1 activation and GLI1 repression require the generation of reactive oxygen species. Collectively, these results define a novel mechanism underlying AA antitumoral functions that may serve as a foundation for future PUFA-based therapeutic approaches.

1 July 2015 in Prostaglandins & Other Lipid Mediators
Verified
Journal Article
Closed access
MVMarianela Vara-Messler
Marianela Vara-Messler
CBCarola Buccellati
Carola Buccellati
LPLinda Pustina
Linda Pustina
GFGiancarlo Folco
Giancarlo Folco
GRGianenrico Rovati
Gianenrico Rovati
MHMalvina Hoxha
Malvina Hoxha